Recent Finacing
Recent Raise
Action Pharma, a Denmark-based biotech developing melanocortin receptor therapeutics, is advancing AP214 in phase 2 trials to prevent acute kidney injury after cardiac surgery and seek clinical partnering
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
